HopeStage
Study directory

Depression studies

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

Back to overview
More filters: keywords, city, remote
7264studies shown
Showing 181-192 of 7,264
Drug study icon
RecruitingNCT06966401

NBI-1065845 for depression

What is this study about?

This study evaluates the safety of NBI-1065845 for people with depression.

Multiple locations, including Huntsville
DepressionMedication studyAges 18+
Countries
United States, Canada, United Kingdom, + 17 others
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
RecruitingNCT06911112

NBI-1065845 for depression

What is this study about?

This study evaluates the safety and effectiveness of NBI-1065845 for people with depression.

Multiple locations, including Huntsville
DepressionMedication studyAges 18+
Countries
United States, Bulgaria, Lithuania, + 2 others
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
RecruitingNCT06963021

NBI-1065845 for depression

What is this study about?

This study evaluates the safety and effectiveness of NBI-1065845 for people with depression.

Multiple locations, including Chino
DepressionMedication studyAges 18+
Countries
United States, Canada, United Kingdom, + 4 others
Sponsor
Neurocrine Biosciences (Biotech company)
Device study icon
RecruitingNCT04556890

Pain and Major Depressive Disorder

Official study title

Multi-target Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Major Depressive Disorder (MDD) and Comorbid Pain

In Los Angeles
DepressionDevice studyAges 18–75
Countries
United States
Sponsor
University of California, Los Angeles
Behavioral study icon
RecruitingNCT06110897

RESISTance Exercise for Depression study

What is this study about?

This study evaluates the effectiveness of exercise for people with depression.

In Madison
DepressionBehavioural studyAges 18–65
Countries
United States
Sponsor
University of Wisconsin, Madison
Drug study icon
RecruitingNCT05922878

ALTO-300 in MDD

What is this study about?

Researchers are comparing ALTO-300 and placebo to find out how the approaches affect depression symptoms in adults with depression.

Multiple locations, including Phoenix
DepressionMedication studyAges 18–70
Countries
United States
Sponsor
Alto Neuroscience
Drug study icon
RecruitingNCT06786624

NBI-1065845 for depression

What is this study about?

This study evaluates the safety and effectiveness of NBI-1065845 for people with depression.

Multiple locations, including Little Rock
DepressionMedication studyAges 18+
Countries
United States
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
Not Yet RecruitingNCT06545474

Effects of rTMS Compared to SSRI as Early Treatment of Depression (Early-TMS)

Official study title

Repetitive Transcranial Magnetic Stimulation (rTMS) as an Early Intervention in Major Depression (MD) Compared to Antidepressant Selective Serotonin Reuptake Inhibitor (SSRI) Medication (Early-TMS)

This study isn't recruiting yet.

Location not clearly listed
DepressionMedication studyAges 18–65
Countries
Sponsor
University Hospital Tuebingen
Behavioral study icon
Not Yet RecruitingNCT06229652

Stress Management in Depressive Disorder: Resilience Training vs. Yoga: Biological, Epigenetic, and Brain Correlates

Official study title

The Impact of Stress Management Interventions on Stress Perception, Coping Strategies, and Residual Symptoms in Depression: a Randomized Controlled Trial Investigating Psychological, Biological, Epigenetic, and Brain Correlates

This study isn't recruiting yet.

In Innsbruck
DepressionBehavioural studyAges 18–65
Countries
Austria
Sponsor
Medical University Innsbruck
Device study icon
Enrolling By InvitationNCT07369180

NQ Square TMS for MDD 1Dx3S Adults Multi-site Sham-controlled Protocol

Official study title

Safety and Efficacy of an Accelerated, Rectangular Waveform rTMS Protocol in Treatment of Adults With Major Depressive Disorder.

This study is by invitation only.

Multiple locations, including Campbell
DepressionDevice studyAges 22–85
Countries
United States
Sponsor
NeuroQore Inc.
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.